|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - October 2001
IgA myeloma associated with decreased anion gap and renal failure. Normal frequencies of the C677T genotypes on the methylenetetrahydrofolate reductase (MTHFR) gene among [Osmotic activity of plasma in plasmapheresis in patients with multiple ... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - September 2001
Table of ContentsApoptosis in multiple myeloma: therapeutic implications.Analysis of clonal relationship using single-cell polymerase chain reaction in a patient with concomitant mantle cell lymphoma and multiple myeloma.[Laryngeal... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - April 2002
Autocrine production and synergistic growth-promoting activity of interleukin-6 and oncostatin M in a new human myeloma cell line TU-1. Hepatic failure due to CD3+ plasma cell infiltration of the liver in multiple myeloma. Hypothyroidism... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - August 2002
Clinical images: osteosclerotic myeloma associated with the POEMS syndrome. Myeloma and monoclonal gammopathy of uncertain significance associated with acquired von Willebrand's syndrome. Seven new cases with a Thalidomide in the... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - February 2002
Deep venous thrombosis and thalidomide therapy for multiple myeloma. The revitalization of thalidomide. Thalidomide and dexamethasone combination for refractory multiple myeloma. Association and contribution of ERK to IL-6-induced activation of... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - January 2002
High-dose melphalan with G-CSF-stimulated whole blood rescue followed by stem cell harvesting and busulphan/cyclophosphamide with autologous stem Thalidomide: near complete regression of extramedullary bulk in refractory multiple myeloma.... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - July 2002
Bone marrow transplantation for multiple myeloma: where we are today. Optimizing dendritic cell-based immunotherapy in multiple myeloma. Interleukin 6 and tumour necrosis factor alpha serum levels in monoclonal gammopathy of undetermined... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - June 2002
[New trends in the therapy of myeloma] Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin Beta, in hematologic malignancies. IgM myeloma: a report of four cases. Multiple myeloma following an... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - March 2002
Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - May 2002
The role of high-dose chemotherapy and stem-cell transplantation in patients with multiple myeloma: a practice guideline of the Cancer Care Unilateral sixth cranial nerve palsy caused by skull base mass lesions: case series. Are myeloma... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - October 2002
Changes in T cell receptor repertoire associated with graft-versus-tumor effect and graft-versus-host disease in patients with relapsed multiple [Signal transduction and biological function of IL-6 in a human myeloma cell line-XG-7] ... |
|
|
NCI CANCERLIT® Search: Plasma Cell Neoplasm - September 2002
Tender preauricular swelling. IgA myeloma presenting as diabetes mellitus with refractory anaemia. [Breast plasmacytoma. A new case] [Plasma cell leukemia: aggressive form of multiple myeloma] Second response to lower-dose thalidomide in a... |
|
|
NCI/PDQ® Health professionals: Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®)
TABLE OF CONTENTS General Information About Plasma Cell Neoplasms Incidence and MortalityClinical Presentation and EvaluationEvaluation of patients with monoclonal (or myeloma) protein (M protein)Monoclonal Gammopathy of Undetermined Significance... |
|
|
NCI/PDQ® Pacientes:
TABLE OF CONTENTS Descripción¿Qué es la neoplasia de células plasmáticas?Explicación de los estadiosEstadios de la neoplasia de células plasmáticasMieloma móltipleMieloma móltiple en estadio IMieloma... |
|
|
NCI/PDQ® Patients: Multiple Myeloma and Other Plasma Cell Neoplasms
TABLE OF CONTENTS DescriptionWhat are plasma cell neoplasms?Stage ExplanationStages of plasma cell neoplasmsMultiple myelomaStage I multiple myelomaStage II multiple myelomaStage III multiple myelomaIsolated plasmacytoma of boneExtramedullary... |
|
|
NCI/PDQ® Profesionales De Salud: Neoplasias de células plasmáticas (incluso mieloma móltiple): Tratamiento (PDQ®)
TABLE OF CONTENTS Información general sobre las neoplasias de células plasmáticasIncidencia y mortalidadPresentación clínica y evaluaciónEvaluación de pacientes con proteína (proteína M) monoclonal (o... |